ClinicalTrials.gov
public full text
Public Domain
Interaction Between Nalbuphine and Morphine in PCA
1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist 2. This study was designed to investigate the interaction between nalbuphine and morphine
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mu opioid receptor mRNA and protein localization across the rat and mouse habenula#245274
- Therapeutic Potential of Kappa-Opioids Against Cocaine - 1#845624
- Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder#1096601
- Nonpharmacological and pharmacological influences on opioid effects: A review of clinical research findings.#285207
- Rational design of a Kappa opioid receptor peptide agonist with attenuated β-arrestin signaling.#297366
Record · ID 1172462
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive